Jagsonpal Pharmaceuticals standalone net profit rises 82.29% in the September 2021 quarter
Sales rise 5.57% to Rs 59.49 crore
Net profit of Jagsonpal Pharmaceuticals rose 82.29% to Rs 7.31 crore in the quarter ended September 2021 as against Rs 4.01 crore during the previous quarter ended September 2020. Sales rose 5.57% to Rs 59.49 crore in the quarter ended September 2021 as against Rs 56.35 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales59.4956.35 6 OPM %17.308.59 -PBDT10.515.13 105 PBT10.284.86 112 NP7.314.01 82Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 20 2021 | 7:42 AM IST